HLB HLB Inc. Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
03:19
Jan 12
Jan 12
Korean biotech is a buy on dip
Korean biotech is a buy-on-dip opportunity: JPMorgan Healthcare Conference catalysts, KOSDAQ activation policy, and event-driven selloffs create entry points for quality bio names.
HIGH
About HLB Investor Commentary
Across the available history and selected sources, Buzzberg tracks HLB (HLB Inc.) across 1 sources: 1 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Latest voices: Lee Yoon-hee.